Neuromyelitis Optica Spectrum Disorders in North Indian Population: Experience from a Tertiary Care Center

被引:3
|
作者
Sachdeva, Julie [1 ]
Goyal, Manoj K. [1 ]
Singh, Ramandeep [2 ]
Kapila, Aastha T. [1 ]
Singh, Paramjeet [3 ]
Saikia, Biman [4 ]
Lal, Vivek [1 ]
机构
[1] PGIMER, Dept Neurol, Chandigarh, India
[2] PGIMER, Dept Ophthalmol, Chandigarh, India
[3] PGIMER, Dept Radiodiag & Intervent Radiol, Chandigarh, India
[4] PGIMER, Dept Immunopathol, Chandigarh, India
关键词
Neuromyelitis optica; North Indian; NMOSD; AQUAPORIN; 4; AQP4; MOG;
D O I
10.4103/0028-3886.355118
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: To understand neuromyelitis optica spectrum disorders (NMOSDs) better we need to study them in different populations. This prospective study was conducted to characterize clinical, serological, radiological, and therapeutic profile of NMOSDs in a North Indian population. Materials and Methods: This study included 81 patients with NMOSDs. All patients underwent detailed history and examinations and were followed at 3 monthly intervals. They were evaluated using standard investigations including gadolinium-enhanced magnetic resonance imaging (MRI) of the brain and spine with thin section optic nerve cuts and treated as per the standard guidelines. Data were recorded meticulously. Results: The mean age was 33.7 +/- 13.4 years. The mean age at disease onset was 31.2 +/- 13.5 years. Female-to-male ratio was 1.9:1. About 32.1% of patients presented with optic neuritis (ON), 56.8% with transverse myelitis (TM), and 11.1% with both ON and TM. The mean time from disease onset to diagnosis was 16.17 +/- 23.09 months. Muscle atrophy, Lhermitte symptom, and tonic spasms were common. Foster-Kennedy syndrome-like presentation was seen in 8.6%. NMO antibodies were positive in 41 patients. MRI revealed involvement of <4 vertebral segments in 16.4% of patients with TM. Patients were managed as per standard guidelines. The mean follow-up duration was 15.3 +/- 6 months. Approximately 88.9% had good functional outcome. Conclusion: NMOSDs are a common cause of demyelinating illnesses in Northern India. The response to treatment is excellent and most patients recover without residual disability.
引用
收藏
页码:1500 / 1505
页数:6
相关论文
共 50 条
  • [31] Neuromyelitis optica spectrum disorders: an update
    Palace, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 23 - 23
  • [32] Neuromyelitis Optica Spectrum Disorders (NMOSD)
    Christopher C. Glisson
    Current Treatment Options in Neurology, 2022, 24 : 241 - 251
  • [33] Neuromyelitis optica spectrum disorders: An update
    Pandit, Lekha
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2015, 18 : S11 - S15
  • [34] Neuromyelitis optica spectrum disorders in Algeria
    Daoudi, S.
    Bouzar, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 344 - 344
  • [35] Imaging of Neuromyelitis Optica Spectrum Disorders
    Hung, Sheng-Che
    SEMINARS IN ULTRASOUND CT AND MRI, 2020, 41 (03) : 319 - 331
  • [36] Neuromyelitis Optica spectrum disorders in the elderly
    Boudanga, Assma
    Chraa, Mohamed
    Kissani, Najib
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 30 - 30
  • [37] Neuromyelitis optica spectrum disorders and polyautoimmunity
    Correia, A. S.
    Takley, G.
    Woodhall, M.
    Nour, J.
    Gore, R.
    Waters, P.
    Palace, J.
    Leite, M. I.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 655 - 656
  • [38] A Comparison of Pediatric and Adult Neuromyelitis Optica (NMO) at a Tertiary Care Center
    McGill, B. E.
    Ostendorf, A. P.
    Alvarez, E.
    Mar, S. S.
    ANNALS OF NEUROLOGY, 2013, 74 : S139 - S139
  • [39] Immunobiology of neuromyelitis optica spectrum disorders
    Cuervo, Daissy Liliana Mora
    Hansel, Gisele
    Sato, Douglas Kazutoshi
    CURRENT OPINION IN NEUROBIOLOGY, 2022, 76
  • [40] Treatment of Neuromyelitis Optica Spectrum Disorders
    Chan, Koon-Ho
    Lee, Chi-Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)